Guard Therapeutics receives conditional approval for continued listing

Biotech company Guard Therapeutics has received conditional approval from Nasdaq Stockholm for continued listing of its shares on Nasdaq First North.

Guard Therapeutics, a Swedish biotech company, has received conditional approval from Nasdaq Stockholm. The approval concerns continued listing of the company's shares on Nasdaq First North.

The decision was announced on July 16, 2026. It allows the company to remain on the marketplace under certain conditions.

Makala yanayohusiana

Illustration of stock exchanges affected by postponed KNDS IPO amid defense stock volatility, with flags and concerned executives.
Picha iliyoundwa na AI

KNDS postpones IPO amid volatility in defense stocks

Imeripotiwa na AI Picha iliyoundwa na AI

The German-French defense company KNDS has postponed its planned stock market listing in Paris and Frankfurt. The firm wants to wait for better market conditions. The German government is sticking to its planned entry nonetheless.

Medical technology company SpectraCure in Lund is carrying out a rights issue that will add 34.2 million kronor if fully subscribed. The issue will finance clinical studies and regulatory applications. The share fell more than 20 percent on Monday.

Imeripotiwa na AI

Enhanced Group Inc. started trading on the NYSE in early May following its combination with Paradise Acquisition Corp. The telehealth firm focuses on peptides and performance-enhancing products.

Biotech company Carbiotix in Lund has been declared bankrupt. The firm was delisted from Spotlight Stock Market at the end of last year.

Imeripotiwa na AI

ARS Pharmaceuticals held its first quarter 2026 earnings conference call on May 15, highlighting early momentum in the new year. Company executives emphasized growth drivers including expanded access for its neffy product. The call featured forward-looking statements about the firm's commercial progress.

Danish drugmaker Novo Nordisk is taking a local compounding pharmacy to court in Pretoria to stop the sale of unregistered semaglutide products. The High Court application targets iDexis over patient safety concerns.

Imeripotiwa na AI

The Egyptian government has confirmed plans to list four Armed Forces-affiliated companies on the Egyptian Exchange during a Wednesday meeting chaired by Prime Minister Mostafa Madbouly.

Alhamisi, 25. Mwezi wa sita 2026, 07:50:41

Bayer wins glyphosate dispute before the Supreme Court

Jumapili, 21. Mwezi wa sita 2026, 20:52:29

European Bitcoin firms advance financing plans for treasury strategies

Jumatano, 10. Mwezi wa sita 2026, 03:39:20

Egypt identifies 61,000 companies eligible for EGX listing

Alhamisi, 4. Mwezi wa sita 2026, 21:57:09

Nubank shares rise 4% in New York after finance chief exit

Jumamosi, 23. Mwezi wa tano 2026, 06:49:42

Egypt’s FRA approves licences for eight companies

Jumatano, 20. Mwezi wa tano 2026, 15:49:27

Gland Pharma shares hit 52-week high after results

Jumatano, 20. Mwezi wa tano 2026, 15:46:11

Ethio telecom launches share trading on ethiopian securities exchange

Ijumaa, 15. Mwezi wa tano 2026, 04:47:23

KNDS advances IPO plans without awaiting government decision

Alhamisi, 14. Mwezi wa tano 2026, 00:38:57

Inovio Pharmaceuticals reviews Q1 results and INO-3107 FDA status

Alhamisi, 30. Mwezi wa nne 2026, 05:54:02

Syntara reports positive FDA feedback on amsulostat trial

 

 

 

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa